Clinical Trials

Advancing Health Through Innovation: Clinical Trials at Tulane School of Medicine

 

Clinical trials at Tulane School of Medicine play a vital role in advancing medical knowledge and improving patient care. With a strong commitment to translating scientific discoveries into real-world health solutions, researchers work collaboratively across disciplines to bring innovative treatment and prevention options to patients—often before they become widely available.

Support services are available to guide the full lifecycle of clinical trials, from study initiation to patient coordination and data collection. These trials are essential for developing new standards of care, especially in areas like cancer, where access to investigational therapies can offer patients additional hope and cutting-edge options.

At the heart of this work is a dedication to patient safety, research integrity, and education—ensuring that every clinical trial contributes meaningfully to the future of medicine.

Clinical Trials Day 2025

Tuesday, May 20th is Clinical Trials Day! In appreciation of the importance of the clinical research work performed by members of the Tulane community, the Tulane School of Medicine, the Tulane Center for Clinical Research, and the Tulane Cancer Center are hosting a casual reception to celebrate all the Investigators, Research Nurses, Coordinators, Administrators, and other professionals who make clinical research possible. 

Please stop by on Tuesday, May 20th, in the EJGH lobby anytime between 9 am and 12 pm or the Murphy lobby anytime between 1 and 4 pm. Enjoy refreshments, prizes, and more as we celebrate Clinical Trials Day!

Where: Murphy  Innovation Center
When: Tuesday, May 20th from 1:00 to 5:00 p.m.

For questions: Please contact tccr@tulane.edu 

Ongoing Clinical Trials


 



 

This study is testing a new method of measuring blood clotting using small samples from finger pricks. Researchers want to compare these results…

Blood clotting
HSV Stock Photo

This clinical trial is testing pritelivir, a new antiviral medication, in people with weakened immune systems who have herpes simplex virus (HSV)…

Herpes Simplex Virus
This is an AI generated image of a lung MRI

This NIH-funded study tests whether inhaled budesonide and formoterol can prevent acute respiratory failure (ARF). Though FDA-approved for asthma…

Pneumonia, Respiratory Failure

View the Clinical Trials Diretory

TCCR Unit

Contact Us

Tulane Center for Clinical Research (TCCR)

Mailing Address 
1440 Canal Street #8471
New Orleans, LA  70112
phone: 504-988-0200
fax: 504-988-0239
tccr@tulane.edu 

Physical Location 
1440 Canal Street 
Suite 1700 
New Orleans, LA 70112